Literature DB >> 17589892

Metabolism of high density lipoproteins in liver cancer.

Jing-Ting Jiang1, Ning Xu, Chang-Ping Wu.   

Abstract

Liver plays a vital role in the production and catabolism of plasma lipoproteins. It depends on the integrity of cellular function of liver, which ensures homeostasis of lipid and lipoprotein metabolism. When liver cancer occurs these processes are impaired and high-density lipoproteins are changed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17589892      PMCID： PMC4436599          DOI： 10.3748/wjg.v13.i23.3159

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  66 in total

1.  Differential tissue-specific expression of human apoA-I and apoA-II.

Authors:  T L Eggerman; J M Hoeg; M S Meng; A Tombragel; D Bojanovski; H B Brewer
Journal:  J Lipid Res       Date:  1991-05       Impact factor: 5.922

Review 2.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

3.  Low hepatic lipase activity is a novel risk factor for coronary artery disease.

Authors:  K A Dugi; K Brandauer; N Schmidt; B Nau; J G Schneider; S Mentz; T Keiper; J R Schaefer; C Meissner; H Kather; M L Bahner; W Fiehn; J Kreuzer
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

4.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

Authors:  G R Castro; C J Fielding
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

5.  Pathway of cholesterol efflux from human hepatoma cells.

Authors:  D Sviridov; N Fidge
Journal:  Biochim Biophys Acta       Date:  1995-05-17

6.  Structural and functional analysis of the promoter of the hepatic lipase gene.

Authors:  S F Chang; J G Scharf; H Will
Journal:  Eur J Biochem       Date:  1997-07-01

7.  High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.

Authors:  Bin Lou; Xue-Ling Liao; Man-Ping Wu; Pei-Fang Cheng; Chun-Yan Yin; Zheng Fei
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 8.  Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis.

Authors:  R K Ockner; R M Kaikaus; N M Bass
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

9.  Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux.

Authors:  Jane V Mulcahy; Dave R Riddell; James S Owen
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

10.  Serum apolipoproteins A-I, A-II and B in hepatic metastases. Comparison with other liver diseases: hepatomas and cirrhosis.

Authors:  H Hachem; G Favre; G Raynal; G Blavy; P Canal; G Soula
Journal:  J Clin Chem Clin Biochem       Date:  1986-03
View more
  2 in total

1.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

2.  Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma.

Authors:  Injoon Yeo; Gi-Ae Kim; Hyunsoo Kim; Ji Hyeon Lee; Areum Sohn; Geum-Youn Gwak; Jeong-Hoon Lee; Young-Suk Lim; Youngsoo Kim
Journal:  Hepatol Commun       Date:  2020-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.